Oliver F. Bathe, MD, MSc, FRCSC, FACS, is a Professor of Surgery and Oncology at the University of Calgary and a surgical oncologist at the Arthur J.E. Child Comprehensive Cancer Centre. His clinical and research career has focused on improving cancer outcomes through the integration of surgery, molecular biology, clinical investigation and computational analysis.
Dr. Bathe has led and collaborated on studies in hepatobiliary, pancreatic, gastrointestinal and thyroid cancers. His research program applies transcriptomics and other high-dimensional data to define biologically meaningful tumour subtypes, understand tumour-host interactions and develop molecular tools that can support prognosis and treatment selection. He has contributed to major international cancer genomics initiatives, including TCGA and CPTAC, and has extensive experience in tumour banking, translational research and biomarker development.
He is also the founder and CEO of Qualisure Diagnostics, a University of Calgary spin-off developing RNA-based molecular diagnostics and software infrastructure for the clinical deployment of computational assays. Across his academic and entrepreneurial work, his goal is to make sophisticated molecular information clinically actionable and accessible to patients wherever they receive care. He is actively involved in teaching and mentorship across surgical oncology, cancer biology, translational science and computational medicine.